Follicular fluid protein content (FSH, LH, PG4, E2 and AMH) and polar body aneuploidy

scientific article

Follicular fluid protein content (FSH, LH, PG4, E2 and AMH) and polar body aneuploidy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10815-012-9841-8
P932PMC publication ID3492586
P698PubMed publication ID22890422

P2093author name stringM Albert
M Adler
J Selva
M Bailly
M Bergere
R Wainer
F Vialard
D Molina Gomes
I Hammoud
L Malagrida
P2860cites workDehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)Q21245539
Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injectionQ24244735
Laser microdissection as a new approach to prefertilization genetic diagnosisQ30661800
ESHRE PGD Consortium data collection IV: May-December 2001.Q30976595
Outcome of laser-assisted polar body biopsy and aneuploidy testingQ31122726
Laser-assisted microdissection of the zona pellucida facilitates polar body biopsyQ32072970
Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytesQ33185673
Are zona pellucida laser drilling and polar body biopsy safe for in vitro matured oocytes?Q33585252
High follicle-stimulating hormone increases aneuploidy in human oocytes matured in vitroQ33606372
Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed.Q33880192
Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knewQ33951926
Polar body array CGH for prediction of the status of the corresponding oocyte. Part II: technical aspectsQ34015963
Preimplantation genetic screening: a systematic review and meta-analysis of RCTsQ34181388
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial.Q34357019
Chromosomal abnormalities in oocytesQ34384550
Biomarkers of human oocyte developmental competence expressed in cumulus cells before ICSI: a preliminary studyQ34688490
Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesisQ35117692
Prevention of maternal aging-associated oocyte aneuploidy and meiotic spindle defects in mice by dietary and genetic strategiesQ35134078
Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical resultsQ35389273
Polar body morphology is not predictive of its cell division originQ35722529
Over a decade of experience with preimplantation genetic diagnosis: a multicenter reportQ35859368
Multiple meiotic errors caused by predivision of chromatids in women of advanced maternal age undergoing in vitro fertilisationQ36035686
Preimplantation genetic diagnosis for aneuploidy screening in repeated implantation failureQ36093458
Chromosome 21 detection in human oocyte fluorescence in situ hybridization: possible effect of maternal ageQ36268516
Prevention of age-related aneuploidies by polar body testing of oocytes.Q36271707
Embryo aneuploidy screening for repeated implantation failure and unexplained recurrent miscarriage.Q36527052
The origin of human aneuploidy: where we have been, where we are goingQ36958145
Gamete cytogenetic study in couples with implantation failure: aneuploidy rate is increased in both couple members.Q36995761
IVF/ICSI with or without preimplantation genetic screening for aneuploidy in couples without genetic disorders: a systematic review and meta-analysisQ37284506
Human cumulus cells as biomarkers for embryo and pregnancy outcomesQ37740724
Predisposition to aneuploidy in the oocyteQ37845069
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trialQ40254344
Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphologyQ40394248
The influence of intrinsic and extrinsic factors on the developmental potential and chromosomal normality of the human oocyte.Q41105279
Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes.Q42491370
Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cyclesQ42494908
The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryosQ43132928
Basal FSH, estradiol and inhibin B concentrations in women with a previous Down's syndrome affected pregnancyQ43833603
Follicle-stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitroQ45061653
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatmentQ45234419
The cytogenetics of polar bodies: insights into female meiosis and the diagnosis of aneuploidyQ45844850
Ovarian stimulation and the risk of aneuploid conceptionsQ45984200
Basal follicle-stimulating hormone as a predictor of fetal aneuploidyQ46188678
Perifollicular vascularity in poor ovarian responders during IVF.Q46952688
Human cumulus cell gene expression as a biomarker of pregnancy outcome after single embryo transfer.Q48673269
Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failureQ48718141
Chromosomal aneuploidy in embryos conceived with unstimulated cycle IVF.Q48744843
Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilizationQ48791608
Oocyte aneuploidy mechanisms are different in two situations of increased chromosomal risk: older patients and patients with recurrent implantation failure after in vitro fertilization.Q48793829
Robust embryo identification using first polar body single nucleotide polymorphism microarray-based DNA fingerprintingQ48831615
Chromosomal abnormalities in a series of 6,733 human oocytes in preimplantation diagnosis for age-related aneuploidies.Q48832214
Mechanisms of non-disjunction in human female meiosis: the co-existence of two modes of malsegregation evidenced by the karyotyping of 1397 in-vitro unfertilized oocytesQ48854145
Experimental evidence that changes in oocyte growth influence meiotic chromosome segregationQ48861937
Selection of the most common chromosome abnormalities in oocytes prior to ICSI.Q48886368
The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristicsQ48958485
Cigarette smoking may affect meiotic maturation of human oocytesQ49029679
First meiosis errors in immature oocytes generated by stimulated cycles.Q50647697
Meiotic spindle configuration is differentially influenced by FSH and epidermal growth factor during in vitro maturation of mouse oocytes.Q50651543
Evidence of a high proportion of premature unbalanced separation of sister chromatids in the first polar bodies of women of advanced age.Q50653770
Differential effects of repeated ovarian stimulation on cytoplasmic and spindle organization in metaphase II mouse oocytes matured in vivo and in vitro.Q50716927
Birth of healthy children after preimplantation diagnosis of common aneuploidies by polar body fluorescent in situ hybridization analysis. Preimplantation Genetics Group.Q50761621
Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer.Q51678170
[Contribution of first polar body analysis to understanding of human aneuploidy mechanism].Q53620387
[The cytogenetics of human oocytes: 40 years of progress]Q53674410
Treatment-related chromosome abnormalities in human embryosQ57779469
Cytogenetic analysis of unfertilized oocytes retrieved after treatment with the LHRH analogue, buserelinQ68368809
Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridizationQ73108832
Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridizationQ73621662
Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidyQ77323484
[Maternal age and chromosomal abnormalities in human oocytes]Q80493031
Advanced maternal age--how old is too old?Q80961581
Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVFQ81196488
Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trialQ81533938
P433issue10
P304page(s)1123-1134
P577publication date2012-08-14
P1433published inJournal of Assisted Reproduction and GeneticsQ15755113
P1476titleFollicular fluid protein content (FSH, LH, PG4, E2 and AMH) and polar body aneuploidy
P478volume29

Reverse relations

cites work (P2860)
Q36625099Activin Decoy Receptor ActRIIB:Fc Lowers FSH and Therapeutically Restores Oocyte Yield, Prevents Oocyte Chromosome Misalignments and Spindle Aberrations, and Increases Fertility in Midlife Female SAMP8 Mice
Q64115264Anti-Müllerian Hormone Gene Polymorphism is Associated with Clinical Pregnancy of Fresh IVF Cycles
Q35186882Preliminary proteomic analysis on the alterations in follicular fluid proteins from women undergoing natural cycles or controlled ovarian hyperstimulation
Q47176567Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval.

Search more.